Eli Lilly's investigational triple receptor agonist Retatrutide supplied as lyophilised powder in 5mg to 60mg vials. 99%+ HPLC and Mass Spectrometry verified. Strictly for in-vitro laboratory research.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.